Generic Name and Formulations:
Anthralin 1.2% (microcrystalline encapsulated); rapid-release cream.
- Young Adult, Adolescent Survivors of Cancer May Have Increased Long-Term Risk for Endocrine Disease
- Achieving Long-Term Viral Suppression May Reduce Risk of AIDS-Related Cancers
- Daratumumab Plus Carfilzomib, Dexamethasone May Be Effective in Lenalidomide-Refractory Multiple Myeloma
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
- Waldenstrom's Macroglobulinemia/ Lymphoplasmacytic Lymphoma Treatment Regimens
Indications for ZITHRANOL-RR:
Stable plaque psoriasis.
Initially apply once daily (5–15 minutes contact time) for at least one week; may increase contact time to 30 minutes before washing off. Individualize. For skin: use sparingly. For scalp: wash and rinse hair; apply cream while hair is damp; may repeat treatment on alternate days.
Acute or actively inflamed psoriatic eruptions.
Avoid eyes, mucous membranes. Apply cautiously on the face or intertriginous skin areas. Discontinue if sensitization or excessive irritation develops. May stain fabrics; avoid. Pregnancy (Cat.C). Nursing mothers.
Possible contact allergic reactions, discolored hair or fingernails.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Light Therapy May Prevent Depression During Hospitalization Post-Transplant in Multiple Myeloma
- Re-treatment With Checkpoint Inhibitors in Some Patients with NSCLC May Be Feasible
- TNFi Not Linked to Increased Risk for Cancer Recurrence in Rheumatoid Arthritis
- IL-23 Drives Castration-Resistant Prostate Cancer
- Immediate Instillation of Mitomycin C Post-TURBT May Benefit All Patients with Bladder Cancer